Tag: NIH
-
Univ Lab, Spin-Off Developing Drug from Turmeric
28 October 2015. A university biochemistry lab and spin-off enterprise developing drugs from plants are collaborating on a process for extracting a key ingredient for an anti-inflammatory compound from the common spice turmeric. The project, bringing together the lab of biochemistry professor David Gang at Washington State University and Botanisol LLC in Scottsdale, Arizona, is…
-
Chip Device in Development to Simulate Human Gut
9 October 2015. A team of medical researchers and engineers in North Carolina is developing a miniaturized device derived from human stem cells to better simulate the workings of a human gut. The five-year project is funded by $5.3 million grant from National Institute of Diabetes and Digestive and Kidney Diseases, part of National Institutes…
-
Nanotech Cancer Center Gains $10.1M Funding
1 October 2015. Cornell University and Memorial Sloan Kettering Cancer Center are developing cancer diagnostics and therapies with nanoscale particles, funded largely by a National Cancer Institute grant. NCI, part of National Institutes of Health, is providing $8.2 million to the institutions over five years, while Sloan Kettering is adding $1.9 million. Cornell and Sloan…
-
Clinical Trial Underway Testing Cancer Surgery Aid
22 September 2015. A clinical trial is enrolling patients with soft tissue sarcoma to test a synthetic peptide that illuminates cancer cells to make them more easily removed during surgery. The early-stage study is testing the safety of the peptide made by Blaze Bioscience Inc. in Seattle and conducted at Cedars-Sinai Medical Center in Los…
-
NIH Backing Alzheimer’s Onset Drug Trial
15 September 2015. National Institute on Aging, part of National Institutes of Health, is funding a late-stage clinical trial testing a current epilepsy drug as a treatment to delay the early onset of Alzheimer’s symptoms. The $7.5 million grant, part of NIH’s national plan to address Alzheimer’s disease, supports the trial testing a low-dose formulation…
-
Grant Funds Research on Nanotech Cancer Treatments
1 September 2015. National Cancer Institute is renewing its support for a Northwestern University research center advancing nanotechnology to design new cancer treatments. The Northwestern University Center for Cancer Nanotechnology Excellence is the recipient of a new five-year, $11.7 million grant from National Cancer Institute, part of National Institutes of Health. The Center for Cancer…
-
Small Business Grant Funds Preclinical Lupus Research
24 August 2015. A grant from National Institute of Allergy and Infectious Diseases is funding preclinical research by a biotechnology company on stem cells as a therapy for a type of lupus. The $225,000 grant from NIAID, part of National Institutes of Health, is made to Ocata Therapeutics Inc. of Marlborough, Massachusetts under the institute’s…
-
Cancer Precision Medicine Trial Underway
18 August 2015. A new clinical trial is enrolling participants that tests multiple types of therapies on a number of different cancers based on the genomic make-up of individual patients. The intermediate-stage trial is part of the National Cancer Institute’s Molecular Analysis for Therapy Choice, or NCI-MATCH program. NCI-MATCH seeks to determine if tumors with…
-
Trial Shows Engineered T-Cells Act on Multiple Myeloma
21 July 2015. An early-stage clinical trial shows immune system cells from patients with the blood-related cancer multiple myeloma — modified to attack a protein suspected of helping the cancer grow — generated a positive clinical response in most of the participants. The team from University of Pennsylvania cancer center, University of Maryland medical school,…
-
Univ. of Arizona Spin-Off Licenses Cancer Therapy
10 July 2015. A new company spun-off from University of Arizona licensed a cancer therapy based on research by a pharmacy faculty member at the school, also the company’s founder. Synactix Pharmaceuticals Inc. in Tucson is founded by pharmacology professor Hong-yu Li and postdoctoral fellow Brendan Fett. Li’s lab at Arizona studies cancer therapeutics, particularly…